Annual Working Capital
$9.71 M
-$2.49 M-20.39%
December 31, 2024
Summary
- As of February 27, 2025, NVCT annual working capital is $9.71 million, with the most recent change of -$2.49 million (-20.39%) on December 31, 2024.
- During the last 3 years, NVCT annual working capital has risen by +$6.30 million (+184.50%).
- NVCT annual working capital is now -31.69% below its all-time high of $14.22 million, reached on December 31, 2022.
Performance
NVCT Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$9.71 M
-$1.28 M-11.63%
December 31, 2024
Summary
- As of February 27, 2025, NVCT quarterly working capital is $9.71 million, with the most recent change of -$1.28 million (-11.63%) on December 31, 2024.
- Over the past year, NVCT quarterly working capital has dropped by -$2.49 million (-20.39%).
- NVCT quarterly working capital is now -52.33% below its all-time high of $20.37 million, reached on September 30, 2022.
Performance
NVCT Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
NVCT Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.4% | -20.4% |
| 3 y3 years | +184.5% | -41.8% |
| 5 y5 years | +10000.0% | -41.8% |
NVCT Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -31.7% | +184.5% | -52.3% | +184.5% |
| 5 y | 5-year | -31.7% | >+9999.0% | -52.3% | +184.5% |
| alltime | all time | -31.7% | >+9999.0% | -52.3% | +184.5% |
Nuvectis Pharma Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $9.71 M(-20.4%) | $9.71 M(-11.6%) |
| Sep 2024 | - | $10.99 M(-12.3%) |
| Jun 2024 | - | $12.53 M(-10.7%) |
| Mar 2024 | - | $14.02 M(+14.9%) |
| Dec 2023 | $12.20 M(-14.2%) | $12.20 M(-26.9%) |
| Sep 2023 | - | $16.69 M(-17.9%) |
| Jun 2023 | - | $20.33 M(+65.7%) |
| Mar 2023 | - | $12.27 M(-13.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $14.22 M(+316.5%) | $14.22 M(-30.2%) |
| Sep 2022 | - | $20.37 M(+77.2%) |
| Jun 2022 | - | $11.50 M(-21.0%) |
| Mar 2022 | - | $14.56 M(+326.4%) |
| Dec 2021 | $3.41 M(<-9900.0%) | $3.41 M(-45.9%) |
| Sep 2021 | - | $6.31 M(-7.5%) |
| Jun 2021 | - | $6.83 M |
| Dec 2020 | -$10.00 K | - |
FAQ
- What is Nuvectis Pharma annual working capital?
- What is the all time high annual working capital for Nuvectis Pharma?
- What is Nuvectis Pharma annual working capital year-on-year change?
- What is Nuvectis Pharma quarterly working capital?
- What is the all time high quarterly working capital for Nuvectis Pharma?
- What is Nuvectis Pharma quarterly working capital year-on-year change?
What is Nuvectis Pharma annual working capital?
The current annual working capital of NVCT is $9.71 M
What is the all time high annual working capital for Nuvectis Pharma?
Nuvectis Pharma all-time high annual working capital is $14.22 M
What is Nuvectis Pharma annual working capital year-on-year change?
Over the past year, NVCT annual working capital has changed by -$2.49 M (-20.39%)
What is Nuvectis Pharma quarterly working capital?
The current quarterly working capital of NVCT is $9.71 M
What is the all time high quarterly working capital for Nuvectis Pharma?
Nuvectis Pharma all-time high quarterly working capital is $20.37 M
What is Nuvectis Pharma quarterly working capital year-on-year change?
Over the past year, NVCT quarterly working capital has changed by -$2.49 M (-20.39%)